Breast cancer therapies reduce risk of Alzheimer’s disease and promote estrogenic pathways and action in brain

Worldwide, an ever-increasing number of women are prescribed estrogen-modulating therapies (EMTs) for the treatment of breast cancer. In parallel, aging of the global population of women will contribute to risk of both breast cancer and Alzheimer’s disease. To address the impact of anti-estrogen the...

Descripción completa

Detalles Bibliográficos
Autores principales: Branigan, Gregory L., Torrandell-Haro, Georgina, Chen, Shuhua, Shang, Yuan, Perez-Miller, Samantha, Mao, Zisu, Padilla-Rodriguez, Marco, Cortes-Flores, Helena, Vitali, Francesca, Brinton, Roberta Diaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663748/
https://www.ncbi.nlm.nih.gov/pubmed/38026173
http://dx.doi.org/10.1016/j.isci.2023.108316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663748/
https://www.ncbi.nlm.nih.gov/pubmed/38026173
http://dx.doi.org/10.1016/j.isci.2023.108316

Ejemplares similares